The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States

This economic evaluation aims to support policy-making on the combined use of pre-exposure prophylaxis (PrEP) with HIV vaccines in development by evaluating the potential cost-effectiveness of implementation that would support the design of clinical trials for the assessment of combined product safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamson, Blythe J. S., Carlson, Josh J., Kublin, James G., Garrison, Louis P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492010/
https://www.ncbi.nlm.nih.gov/pubmed/28538691
http://dx.doi.org/10.3390/vaccines5020013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492010/
https://www.ncbi.nlm.nih.gov/pubmed/28538691
http://dx.doi.org/10.3390/vaccines5020013

Ejemplares similares